Pharmaceutical intermediates: The foundation of APIs
Pharmaceutical intermediates or API intermediates are the unsung heroes of drug development. These compounds are key building blocks for the synthesis of active pharmaceutical ingredients. They are an important stepping stone to creating life-saving medicines. These intermediates are often overlooked, but they play a vital role in ensuring the purity, safety, and efficacy of the final drug product.
Explore the range of APIs
Synthetic APIs: These are chemically synthesized drug ingredients that are often characterized by high efficiency and versatility.
Biotech APIs: These APIs are produced using biotechnological processes, which usually involve the use of living organisms for production.
Natural APIs: These APIs are derived from natural sources such as plants, animals, or minerals, harnessing the power of nature.
Peptide APIs: These APIs consist of short sequences of amino acids and are designed to achieve targeted therapeutic effects.
Small molecule APIs: These APIs are characterized by low molecular weight and are usually synthesized through chemical processes.
Complex APIs: These APIs have complex structures that pose challenges for their synthesis.
Generic APIs: Non-branded versions of existing APIs that offer cost-effective alternatives.
High Potency APIs (HPAPIs): These APIs are extremely potent and require specialized handling and production.
Explore Zenfold's Pharmaceutical Intermediates
At Zenfold, our pharmaceutical intermediates are the cornerstone of the drug development process. These essential compounds are the building blocks of Active Pharmaceutical Ingredients (APIs), which are essential components in life-saving medicines.
3-Aminopiperidine: A versatile ingredient in the synthesis of a wide range of pharmaceutical APIs.
Empagliflozin: Essential in the synthesis of diabetes drugs, demonstrating Zenfold's innovative solutions.
Montelukast: An integral part of respiratory disease drug development, reflecting Zenfold's dedication.
Paxlovid: A cutting-edge intermediate for the synthesis of antiviral drugs that address emerging health challenges.
Pregabalin: Aids neurological drug development, highlighting Zenfold's diverse therapeutic profile.
R3-Quinuclidinol: Versatile and applicable across therapeutic areas, demonstrating Zenfold's commitment to excellence.
Rosuvastatin: Essential in the development of drugs to control cholesterol levels, in line with Zenfold's commitment to cardiovascular health.
Ticagrelor: An essential drug in antiplatelet drug development, exemplifies Zenfold's dedication to impactful intermediates.
